Mark H Kaplan

Title: Mark H Kaplan: Innovator in Transgenic Research

Introduction

Mark H Kaplan is a prominent inventor based in Boston, MA (US). He is known for his significant contributions to the field of genetic research, particularly in the development of transgenic models that aid in understanding various biological processes.

Latest Patents

Kaplan holds a patent for "Stat6 deficient transgenic mice." This invention provides methods and compositions for evaluating modulators of the Stat6 signaling pathway. Specifically, it involves transgenic mice that contain a transgene within a Stat6 allele locus, which encodes a selectable marker and displaces the SH2-encoding domain of the Stat6 allele. The transgene is designed to have 3' and 5' regions that are complementary to the natural Stat6 allele, facilitating homologous recombination. These mice serve as valuable animal models for assessing the effects of candidate drugs on hosts deficient in Stat6 function. The invention outlines various methods for creating and utilizing these compositions, particularly for evaluating the impact of candidate drugs and the side effects of Stat6 function inhibitors.

Career Highlights

Mark H Kaplan is affiliated with Harvard College, where he conducts his research and contributes to advancements in genetic engineering. His work has garnered attention for its potential applications in drug development and therapeutic interventions.

Collaborations

Kaplan has collaborated with notable researchers in his field, including Michael J Grusby. Their joint efforts have furthered the understanding of the Stat6 signaling pathway and its implications in various biological contexts.

Conclusion

Mark H Kaplan's innovative work in developing Stat6 deficient transgenic mice exemplifies the intersection of genetics and therapeutic research. His contributions continue to influence the scientific community and pave the way for future advancements in the field.